ORFV can carry TRAP gene expression via intracellular CRISPR/Cas9 gene editing technology

被引:1
作者
Yu, YongZhong [1 ]
Zhang, Fan [1 ]
Duan, Xuyang [1 ]
Yang, ChaoQun [1 ]
Cui, YuDong [1 ]
Yu, Li [2 ]
机构
[1] Heilongjiang Bayi Agr Univ, Coll Biol Sci & Technol, Daqing 163319, Peoples R China
[2] Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Livestock Infect Dis, State Key Lab Vet Biotechnol, 427 Maduan St, Harbin 150001, Peoples R China
关键词
Orf virus; Staphylococcus aureus; TRAP; CRISPR; Cas9; technique; ORFV-TRAP recombinant virus; ENDOTHELIAL GROWTH-FACTOR; VIRUS-INFECTION; PARAPOXVIRUSES; IMMUNITY; GENOMES; PROTEIN; TARGET;
D O I
10.1016/j.jviromet.2022.114652
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Orf is an acute and highly contracted human and animal infection caused by orf virus (ORFV), which mainly affects sheep, goats, and other species. Clinically, opportunistic or conditional pathogens such as Staphylococcus aureus (S. aureus) are often detected in cases of orf, which greatly increases the risk of disease progression and clinical death. It has been reported that TRAP gene products of S. aureus can broadly influence bacterial life and pathogenicity in vivo, and introduction of exogenous TRAP genes may help to inhibit the proliferation of bacteria. In order to achieve the combined control of ORFV and S. aureus, a novel approach to design a S. aureus TRAP gene vaccine using a live attenuated ORFV vector is proposed. In this study, CRISPR/Cas9 gene editing technology was used to disable vascular endothelial growth factor E of ORFV (VEGF-v) and introduced TRAP gene into this position. TRAP gene expression was detected in keratinocytes infected with recombinant virus. The construction and experimental verification of recombinant ORFV (ORFV-v/TRAP) will provide a reference for indepth studies on the prevention and control of mixed infectious disease.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] CRISPR/Cas9 a simple, inexpensive and effective technique for gene editing
    Patrick Ferreira
    Altino Branco Choupina
    Molecular Biology Reports, 2022, 49 : 7079 - 7086
  • [22] Comparison of CRISPR/Cas9 and Cas12a for gene editing in Chlamydomonas reinhardtii
    Ferenczi, Aron
    Fellbaum, Matthew
    Chew, Yen Peng
    Kidner, Catherine
    Molnar, Attila
    ALGAL RESEARCH-BIOMASS BIOFUELS AND BIOPRODUCTS, 2024, 84
  • [23] Crop gene editing against biotic stresses via CRISPR/Cas9 tools: a review
    Bashar, Kazi Khayrul
    Abu Hanif, Md
    ARCHIVES OF PHYTOPATHOLOGY AND PLANT PROTECTION, 2021, 54 (15-16) : 1159 - 1181
  • [24] CRISPR/Cas9 and gene therapy
    Giono, Luciana E.
    MEDICINA-BUENOS AIRES, 2017, 77 (05) : 405 - 409
  • [25] CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein
    Tang, Lichun
    Zeng, Yanting
    Du, Hongzi
    Gong, Mengmeng
    Peng, Jin
    Zhang, Buxi
    Lei, Ming
    Zhao, Fang
    Wang, Weihua
    Li, Xiaowei
    Liu, Jianqiao
    MOLECULAR GENETICS AND GENOMICS, 2017, 292 (03) : 525 - 533
  • [26] Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma
    Yu, Shijing
    Zhao, Ruirui
    Zhang, Bingchen
    Lai, Chunmei
    Li, Linyan
    Shen, Jiangwen
    Tan, Xiarong
    Shao, Jingwei
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 18 (04)
  • [27] CRISPR/Cas9 gene editing: A new hope for transthyretin amyloidosis treatment
    Shahzad, Faizan
    Rehman, Mohammad Ebad Ur
    Basit, Jawad
    Saeed, Sajeel
    Abbas, Khawar
    Farhan, Muhammad
    ANNALS OF MEDICINE AND SURGERY, 2022, 83
  • [28] Application of CRISPR/Cas9 technology in wild apple (Malus sieverii) for paired sites gene editing
    Zhang, Yan
    Zhou, Ping
    Bozorov, Tohir A.
    Zhang, Daoyuan
    PLANT METHODS, 2021, 17 (01)
  • [29] The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases
    Abdelnour, Sameh A.
    Xie, Long
    Hassanin, Abdallah A.
    Zuo, Erwei
    Lu, Yangqing
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [30] A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing
    Chen, Xin-Zhu
    Guo, Rong
    Zhao, Cong
    Xu, Jing
    Song, Hang
    Yu, Hua
    Pilarsky, Christian
    Nainu, Firzan
    Li, Jing-Quan
    Zhou, Xin-Ke
    Zhang, Jian-Ye
    FRONTIERS IN PHARMACOLOGY, 2022, 13